DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Rammes G, Mahal B, Putzke J. et al.
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
Neuropharmacology 2001; 40: 749-760
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.